Guillain-Barré syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea

Neurol Sci. 2022 Mar;43(3):1491-1493. doi: 10.1007/s10072-021-05849-0. Epub 2022 Jan 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19* / prevention & control
  • Guillain-Barre Syndrome* / etiology
  • Humans
  • Republic of Korea
  • SARS-CoV-2
  • Vaccination / adverse effects

Substances

  • BNT162 Vaccine